Description
TOFLIST is a Tofacitinib-based oral therapy designed to manage chronic autoimmune disorders. Tofacitinib works by inhibiting the Janus kinase (JAK) pathway, which plays a key role in the immune response and inflammation. It is prescribed when conventional disease-modifying antirheumatic drugs (DMARDs) fail to provide adequate relief.
Indications:
-
Rheumatoid Arthritis (RA)
-
Psoriatic Arthritis (PsA)
-
Ulcerative Colitis (UC)
-
Off-label: Alopecia Areata, Vitiligo, Atopic Dermatitis (under supervision)
🔹 Key Benefits:
-
Reduces joint pain and stiffness
-
Improves physical function and mobility
-
Helps control chronic gut inflammation (in UC)
-
Slows disease progression
🔹 Directions for Use:
-
Take orally as prescribed by the physician
-
Usually administered twice daily
-
Do not self-medicate; regular monitoring is advised
-
Should be taken with or without food
🔔 Precautions:
-
Requires regular liver function and blood count monitoring
-
Not recommended in active infections or immunocompromised states
-
May increase risk of blood clots or serious infections
💼 Pharma Franchise & Third-Party Manufacturing:
TOFLIST is available for PCD Pharma Franchise and Third-Party Manufacturing. An in-demand immunomodulatory molecule for rheumatology and dermatology divisions.
📞 Partner with us to grow your specialty product portfolio.
